# Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex

> **NCT03453632** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University Hospital, Toulouse** · enrollment: 25 (estimated)

## Conditions studied

- Epidermolysis Bullosa Simplex

## Interventions

- **DRUG:** Botulinic toxin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03453632
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-14
- **Primary completion:** 2023-09
- **Final completion:** 2023-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2023-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03453632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03453632, "Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03453632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*